{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:26:46Z","timestamp":1789979206693,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.urolonc.2010.07.016","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T05:36:52Z","timestamp":1285911412000},"page":"407-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC)"],"prefix":"10.1016","volume":"31","author":[{"given":"Fran\u00e7ois","family":"Audenet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cussenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2010.07.016_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2010.07.016_bib2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2010.07.016_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00345-009-0494-x","article-title":"Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma","volume":"28","author":"Cornu","year":"2010","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.eururo.2006.07.019","article-title":"Upper urinary tract transitional cell carcinoma: Recurrence rate after percutaneous endoscopic resection","volume":"51","author":"Roupret","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1464-410x.2000.00888.x","article-title":"The long-term outcome after laparoscopic nephroureterectomy: A comparison with open nephroureterectomy","volume":"86","author":"McNeill","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2010.07.016_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(19870801)60:3+<574::AID-CNCR2820601524>3.0.CO;2-C","article-title":"Chemotherapy of urothelial tract tumors","volume":"60","author":"Yagoda","year":"1987","journal-title":"Cancer"},{"issue":"Suppl","key":"10.1016\/j.urolonc.2010.07.016_bib7","first-page":"S36","article-title":"Urothelial neoplasms of the kidney and ureter","volume":"117","author":"Genega","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib8","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.juro.2007.01.030","article-title":"Behavior of urothelial carcinoma with respect to anatomical location","volume":"177","author":"Catto","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1464-410X.1998.00800.x","article-title":"The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract","volume":"82","author":"Miyake","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib10","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2010.07.016_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/00000478-200412000-00001","article-title":"Urothelial carcinoma of the renal pelvis: A clinicopathologic study of 130 cases","volume":"28","author":"Olgac","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000107767.56680.f7","article-title":"The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract","volume":"171","author":"Park","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.ju.0000086551.22844.cd","article-title":"Microsatellite instability in urothelial carcinoma of the upper urinary tract","volume":"170","author":"Amira","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2004.04.011","article-title":"EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma","volume":"46","author":"Oosterlinck","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib15","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin vs. methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"von der Maase","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib16","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1200\/JCO.1999.17.10.3173","article-title":"Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy","volume":"17","author":"Bajorin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0959-8049(99)00012-X","article-title":"Prognostic factors in urothelial renal pelvis and ureter tumors: A multicenter Rare Cancer Network study","volume":"35","author":"Ozsahin","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2010.07.016_bib18","doi-asserted-by":"crossref","unstructured":"Bellmunt J, Sylvester R, Bekka N, et al. Randomized phase III study comparing paclitaxel\/cisplatin\/gemcitabine (PCG) and gemcitabine\/cisplatin (GC) in patients with locally advanced (LA) or metastatic (M) urothelial cancer without prior systemic therapy. EORTC 30987. Intergroup Study. Proceedings of the ASCO Congress 2007, Chicago, June 2007. [Abstract 5030].","DOI":"10.1200\/jco.2007.25.18_suppl.lba5030"},{"key":"10.1016\/j.urolonc.2010.07.016_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cncr.21604","article-title":"The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma","volume":"106","author":"Bamias","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2010.07.016_bib20","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1002\/cncr.24460","article-title":"Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: Results of a large phase 2 study","volume":"115","author":"Vaughn","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2010.07.016_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.eururo.2009.01.002","article-title":"The updated EAU guidelines on muscle-invasive and metastatic bladder cancer","volume":"55","author":"Stenzl","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/419028","article-title":"The role of chemotherapy in upper tract urothelial carcinoma","author":"O'Donnell","year":"2009","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000282755","article-title":"Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract","volume":"55","author":"Igawa","year":"1995","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2010.07.016_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","article-title":"Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract","volume":"68","author":"Kwak","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2010.07.016_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000092930","article-title":"Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract","volume":"77","author":"Lee","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2010.07.016_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1464-410X.1998.00746.x","article-title":"Adjuvant chemotherapy for high-risk urothelial transitional cell carcinoma: The Princess Margaret Hospital experience","volume":"82","author":"Michael","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","article-title":"Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma","volume":"15","author":"Soga","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration","volume":"182","author":"Hellenthal","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","article-title":"Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma","volume":"27","author":"Kikuchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib31","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/cncr.24339","article-title":"Carcinoma of the upper urinary tract: Predictors of survival and competing causes of mortality","volume":"115","author":"Inman","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2010.07.016_bib32","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.urology.2005.01.019","article-title":"Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma","volume":"65","author":"Roupret","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2010.07.016_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","article-title":"Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer","volume":"349","author":"Ribic","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2010.07.016_bib34","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1200\/JCO.2008.18.2071","article-title":"Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803","volume":"27","author":"Bertagnolli","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2010.07.016_bib35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2008.07659.x","article-title":"Molecular and histologic markers in urothelial carcinomas of the upper urinary tract","volume":"102","author":"Eltz","year":"2008","journal-title":"BJU Int"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143910001900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143910001900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:59:29Z","timestamp":1761040769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143910001900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1078143910001900"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2010.07.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC)","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2010.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}